Oxcq 200 Tablet contains Hydroxychloroquine 200 mg, an antimalarial and immunomodulatory agent commonly used in the treatment of autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus. Hydroxychloroquine works by modulating the immune system, reducing inflammation and preventing the progression of disease symptoms. It is also effective in the prophylaxis and treatment of certain types of malaria caused by Plasmodium species. Oxcq 200 is indicated for patients requiring long-term management of autoimmune conditions or malaria prophylaxis in endemic areas. The tablet should be administered under medical supervision, with dosage adjusted according to the specific condition and patient response. Common side effects may include gastrointestinal disturbances, headache, and skin reactions, while rare but serious adverse effects such as retinopathy necessitate regular ophthalmologic monitoring during prolonged therapy. Caution is advised in patients with pre-existing retinal or cardiac conditions. Oxcq 200 should be used with care in pregnancy and lactation, only when clearly needed. Concomitant use with other QT-prolonging drugs requires careful monitoring. Patients are advised to adhere strictly to prescribed doses and report any unusual symptoms promptly to their healthcare provider.